NCT05421806View on ClinicalTrials.gov

A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/

CompletedOBSERVATIONAL
Enrollment

399

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

August 28, 2023

Conditions
HIV I Infection
Trial Locations (4)

Unknown

CHU de Nantes, Nantes

Hopital Universitaire Pitie-Salpetriere, Paris

St Louis Hospital, Paris

Guy's Hospital, London

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

NEAT ID Foundation

OTHER